Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Michl, Patrick [VerfasserIn]   i
 Roth, Laura [VerfasserIn]   i
Titel:Female advantage in neoadjuvant pancreatic cancer therapy
Titelzusatz:is it down to macrophages?
Verf.angabe:Patrick Michl, Laura Roth
E-Jahr:2023
Jahr:October 9, 2023
Illustrationen:Illustrationen
Fussnoten:Online veröffentlicht: 9. Oktober 2023 ; Gesehen am 03.01.2024
Titel Quelle:Enthalten in: Gut
Ort Quelle:London : BMJ Publishing Group, 1960
Jahr Quelle:2024
Band/Heft Quelle:73(2024), 2, Seite 214-215
ISSN Quelle:1468-3288
Abstract:Pancreatic cancer still carries the worst survival rate among all solid tumours, mostly due to the absence of early symptoms and a lack of satisfying treatment options, leading to an appalling 5-year survival rate of less than 12%. The only potentially curative treatment option is surgical resection followed by adjuvant chemotherapy. Since pancreatic cancer is usually diagnosed at advanced stage, treatment with curative intent can be provided to only 15-20% of patients. However, even after surgical resection, most patients develop local or systemic recurrence. During recent years, neoadjuvant chemotherapeutic regimens have been introduced for locally advanced or borderline resectable cancers to improve the chances for secondary resection (eg, CONKO007,1 PREOPANC,2 NEOLAP3). However, even after this sequential approach, only for a minority of patients long-term survival can be achieved. In the resectable situation, the role of neoadjuvant therapy remains to be determined, with conflicting results of the few available trials (eg, NEONAX4). - - It is likely that subgroups of patients benefit from neoadjuvant approaches that are yet to be molecularly characterised. Optimising neoadjuvant systemic therapies by identifying these molecular subgroups of patients with clinical benefit from this approach is highly desirable …
DOI:doi:10.1136/gutjnl-2023-330830
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1136/gutjnl-2023-330830
 Volltext: https://gut.bmj.com/content/early/2023/10/09/gutjnl-2023-330830
 DOI: https://doi.org/10.1136/gutjnl-2023-330830
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:CHEMOTHERAPY
 MACROPHAGES
 PANCREATIC CANCER
K10plus-PPN:1877135666
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69156654   QR-Code
zum Seitenanfang